Amedisys Home Health Chattanooga | |
7205 Lee Highway Suite A, Chattanooga, Tennessee 37421 | |
(423) 472-3069 | |
Name | Amedisys Home Health Chattanooga |
---|---|
Location | 7205 Lee Highway Suite A, Chattanooga, Tennessee |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 447156 |
Ownership Type | Proprietary |
Service Area Zip Codes | 37302, 37303, 37304, 37307, 37308, 37309, 37310, 37311, 37312, 37314, 37315, 37317, 37320, 37321, 37322, 37323, 37325, 37326, 37327, 37329, 37331, 37332, 37333, 37336, 37337, 37338, 37340, 37341, 37343, 37347, 37350, 37351, 37353, 37354, 37361, 37362, 37363, 37367, 37369, 37370, 37373, 37374, 37377, 37379, 37380, 37381, 37384, 37385, 37391, 37397, 37402, 37403, 37404, 37405, 37406, 37407, 37408, 37409, 37410, 37411, 37412, 37415, 37416, 37419, 37421, 37742, 37771, 37772, 37774, 37826, 37846, 37874, 37880, 37885, 38559, 38572, 38583, 38585 |
NPI Number | 1326096009 |
Organization Name | AMEDISYS TENNESSEE, LLC |
Doing Business As | AMEDISYS HOME HEALTH |
Address | 7205 Lee Hwy, Suite A, Chattanooga, TN 37421 |
Phone Number | 423-490-1100 |
News Archive
The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
Healthy Mother Wellness & Care, the pioneer in introducing evidence-based scientific midwifery care in India, announced today the formation of The Healthy Mother Foundation, a non-profit trust with the mission to address the lack of affordable, accessible, and high quality maternal and newborn care in urban slums in India.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
› Verified 9 days ago
Quality Rating: |
News Archive
The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
Healthy Mother Wellness & Care, the pioneer in introducing evidence-based scientific midwifery care in India, announced today the formation of The Healthy Mother Foundation, a non-profit trust with the mission to address the lack of affordable, accessible, and high quality maternal and newborn care in urban slums in India.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 99.6 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.3 | 99.6 |
How often the home health team checked patients for depression | 85 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 81.4 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 80.6 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.3 | 96.4 |
News Archive
The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
Healthy Mother Wellness & Care, the pioneer in introducing evidence-based scientific midwifery care in India, announced today the formation of The Healthy Mother Foundation, a non-profit trust with the mission to address the lack of affordable, accessible, and high quality maternal and newborn care in urban slums in India.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 84.6 | 79.6 |
How often patients got better at getting in and out of bed | 90.1 | 81.1 |
How often patients got better at bathing | 90.9 | 82.3 |
How often patients’ breathing improved | 91.3 | 82.8 |
How often patients’ wounds improved or healed after an operation | 97 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 84.2 | 75 |
How often home health patients had to be admitted to the hospital | 15.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.9 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 98 | 94 |
News Archive
The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
Healthy Mother Wellness & Care, the pioneer in introducing evidence-based scientific midwifery care in India, announced today the formation of The Healthy Mother Foundation, a non-profit trust with the mission to address the lack of affordable, accessible, and high quality maternal and newborn care in urban slums in India.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
› Verified 9 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
Healthy Mother Wellness & Care, the pioneer in introducing evidence-based scientific midwifery care in India, announced today the formation of The Healthy Mother Foundation, a non-profit trust with the mission to address the lack of affordable, accessible, and high quality maternal and newborn care in urban slums in India.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
› Verified 9 days ago
The patient survey data of Amedisys Home Health Chattanooga is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 83 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 92 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 86 | 78 |
News Archive
The progression of the artery-clogging disease atherosclerosis is linked to the inability of specialized bone marrow cells to continuously repair damage to the arterial lining, Duke University Medical Center researchers have demonstrated.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
Healthy Mother Wellness & Care, the pioneer in introducing evidence-based scientific midwifery care in India, announced today the formation of The Healthy Mother Foundation, a non-profit trust with the mission to address the lack of affordable, accessible, and high quality maternal and newborn care in urban slums in India.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced it has been included on a list of preliminary additions to the Russell Microcap Index posted by Russell Investments on June 11, 2010 on www.russell.com. These changes are expected to go into effect after the close of trading on Friday, June 25, 2010.
Glenmark Pharmaceuticals Limited announced today that the US Food and Drug Administration has provided Marketing approval to its partner in US, Salix Pharmaceuticals Limited, for Crofelemer 125 mg delayed-release tablets for the symptomatic relief of non-infectious diarrhea in patients with human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) on anti-retroviral therapy (ART).
› Verified 9 days ago
Erlanger Continucare Home Health Location: 4289 Bonny Oaks Drive, Ste 201-a, Chattanooga, Tennessee 37406 Ratings: Phone: (423) 386-1000 | |
Nhc Homecare Chattanooga Location: 5959 Shallowford Road, Suite 539, Chattanooga, Tennessee 37421 Ratings: Phone: (423) 877-1716 | |
Amedisys Home Health Chattanooga Location: 7205 Lee Highway Suite A, Chattanooga, Tennessee 37421 Ratings: Phone: (423) 472-3069 | |
Erlanger Continucare Home Health Location: 4289 Bonny Oaks Drive Suite 201-b, Chattanooga, Tennessee 37406 Ratings: Phone: (423) 386-1152 | |
Kindred At Home Location: 5751 Cornelison Road 6400 Bldg (bldg B) Ste 100, Chattanooga, Tennessee 37411 Ratings: Phone: (423) 892-1122 | |
Chi Memorial Health At Home Location: 1949 Gunbarrel Road Suite 250, Chattanooga, Tennessee 37421 Ratings: Phone: (423) 495-8550 |